Sentences with phrase «diabetes patients by»

That's particularly significant since people with diabetes have a significantly higher risk of developing cardiovascular conditions — and Lilly's drug was shown to cut the cardiovascular - related deaths in diabetes patients by a staggering 38 % in clinical trials.

Not exact matches

Intarcia has completed several late - stage clinical trials in which it uses the pump to deliver a glucose - controlling drug continuously for months — an idea, that if successful (and approved by the FDA) could significantly help patients with type 2 diabetes, fewer than half of whom maintain the recommended glycemic levels.

The worst performer in Buffett's portfolio was DaVita (dva), the health care dialysis company that treats patients with diabetes and whose stock has been punished by uncertainty over the Affordable Care Act, better known as Obamacare.

On the heels of rival diabetes drug maker Novo Nordisk's announcement that it will limit branded drug price hikes to the single digits going forward, U.S. pharma giant Eli Lilly announced Tuesday that it is partnering with benefits manager Express Scripts and a mobile health platform hosted by Blink Health to slash patients» insulin costs.

An early, outsourced clinical research study with real patients was encouraging, but there are many potential pitfalls yet to come, said University of North Carolina diabetes researcher Dr. John Buse, who was briefed by Google on the lens last week.

Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system.

Avandia, a controversial diabetes drug that was thought to increase patients» risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration.

9:45 AM — 10:05 AM Discover Why Fast Company Named Omada the Most Innovative Company of the Year Meet Omada Health: With 87M consumers at risk of diabetes, 75,000 patients treated, 3 years of outcomes data, NetPromoter scores in the 90's, 70 + clients, and looming reimbursement by Medicare for its diabetes prevention online social network, -LSB-...]

Meet Omada Health: With 87M consumers at risk of diabetes, 75,000 patients treated, 3 years of outcomes data, NetPromoter scores in the 90's, 70 + clients, and looming reimbursement by Medicare for its diabetes prevention online social network, Omada has «cracked the code» on integrating consumer technology, medical coaching and big data at scale.

The journals of the American Diabetes Association work toward these goals by publishing high - quality and timely peer - reviewed diabetes research articles, review articles, case studies, and patient infoDiabetes Association work toward these goals by publishing high - quality and timely peer - reviewed diabetes research articles, review articles, case studies, and patient infodiabetes research articles, review articles, case studies, and patient information.

«The 15 measures will help ensure people with diabetes are getting the care they need, and if they're not, Diabetes UK wants people to use the checklist and ask for the standards of care that have been recommended by expert bodies and patients acrossdiabetes are getting the care they need, and if they're not, Diabetes UK wants people to use the checklist and ask for the standards of care that have been recommended by expert bodies and patients acrossDiabetes UK wants people to use the checklist and ask for the standards of care that have been recommended by expert bodies and patients across the UK.

The findings suggest that fenofibrate therapy may be beneficial in the way the researchers hoped: by reducing cardiovascular events in patients with type 2 diabetes who take statins but still have especially high triglycerides levels and low HDL cholesterol levels.

It is characterised by inflammation and scaling of the skin, accompanied by a greater risk of contracting some type of metabolic syndrome, predisposing patients to pathologies, such as obesity, diabetes or cardiovascular diseases.

Beyond laboratory applications, the app could also be used by patients to monitor chronic conditions such as diabetes, or as a public health tool, by enabling the transmission of medical data to health professionals in real time.

In addition, the development of therapies that could potentially halt patients» progression from pancreatic inflammation to diabetes has been hampered by the long lead times needed in order to tell whether a given therapy has an effect.

To investigate, researchers led by Roberto Pisoni, MD (Medical University of South Carolina) analyzed information on 56 patients with diabetes and CKD who had undergone screening for obstructive sleep apnea through the use of a questionnaire.

The researchers therefore believe that the cognitive problems can be explained to a high degree by the risk factors that are common to patients with different types of heart complaint, for example diabetes, high blood pressure and high cholesterol.

Patients with diabetes mostly fall into one of two categories, type 1 diabetics, triggered by autoimmunity at a young age, and type 2 diabetics, caused by metabolic dysfunction of the liver.

Then, to determine if this change was caused just by weight loss, Laferrère paired a control group of patients with gastric bypass patients, matching for age, duration of diabetes, and ethnicity.

Tear samples from patients with diabetes show elevated levels of substance P, which are related to early damage to the corneal nerves, which may contribute to the development of corneal ulcers and poor wound healing in patients with diabetes, according to the pilot study by Maria Markoulli, PhD, MOptom, FAAO, and colleagues of University of New South Wales, Sydney, Australia.

Importantly, in patients whose liver disease improved, there was also an improvement in kidney function even after several adjustments by potential confounding factors such as diabetes, hypertension, concurrent medications and weight loss by itself.

«In addition to creating new beta cells, another issue that needs to be addressed to achieve a cure for type 1 diabetes is that any new beta cells will be attacked by the autoimmune response present in every patient with type 1 diabetes.

By combining data on optometry patient's eyes with advanced computational methods, Indiana University researchers have created a virtual tissue model of diabetes in the eye.

The study, «AKR1B1 promotes basal - like breast cancer progression by a positive feedback loop that activates the EMT program,» which has been published in The Journal of Experimental Medicine, suggests that an inhibitor of this enzyme currently used to treat diabetes patients could be an effective therapy for this frequently deadly form of cancer.

They've figured out how to turn human stem cells into functional pancreatic β cells — the same cells that are destroyed by the body's own immune system in type 1 diabetes patients.

One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr Johannes Gho, a cardiology resident at the University Medical Center Utrecht, in Utrecht, the Netherlands.1 Risk factors included older age, greater socioeconomic deprivation, and comorbidities such as diabetes.

Atopic dermatitis, psoriasis and chronic venous leg ulcers — typically caused by diabetes or varicose veins — can cause patients years of suffering.

«This is a very exciting finding, obtained by studying patients» cells, that has the potential to result in a new treatment for this chronic complication of longstanding Type 1 diabetes,» Dr. Folli said.

If replicated in humans, this effect could significantly delay, and potentially prevent, the need for chronic insulin use by Type 1 diabetes patients, and help minimize diabetes - related complications.

More than half of this economic cost (56 %, $ 10.8 billion) was on accessing diabetes treatment, including medication and hospital stays — and one half of these costs were out - of - pocket (paid for by the patients), putting a huge financial burden on people with diabetes.

Patients with Type I diabetes lack insulin, which is normally produced by the pancreas and regulates metabolism by stimulating muscle and fat tissue to absorb glucose from the bloodstream.

Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnea are at greater risk of developing a condition that leads to blindness within an average period of less than four years.

The Mayo task force does not recommend in favor of or against the use of statins in patients with diabetes in whom the risk for heart attacks or stroke is low based on the calculator proposed by the ACC / AHA.

There is a lot of work still to do, and many potential pitfalls before it could be applied to human patients, but in principle almost any illness caused by damaged or ageing tissue — heart disease, diabetes, Alzheimer's and dozens of others — could be fixed this way.

The second question is more difficult to answer than it might seem because the low prevalence of cancer and diabetes in Laron patients is counterbalanced by an abnormally high risk of death from other causes, especially accidents, alcohol, and convulsive disorders.

For this study, the researchers used data from a population of patients with both diabetes and chronic kidney disease (stage 3 and 4) enrolled in follow up studies conducted by Dr. Krolewski and his team at the Joslin Diabetes Center and followed for four to 1diabetes and chronic kidney disease (stage 3 and 4) enrolled in follow up studies conducted by Dr. Krolewski and his team at the Joslin Diabetes Center and followed for four to 1Diabetes Center and followed for four to 15 years.

While patients» hemoglobin A1C (HbA1c) levels did not go down, a necessary indicator that testosterone can help control diabetes, Dandona noted that fasting glucose levels had diminished significantly, by 12 milligrams per deciliter.

A new study by researchers from the University of Chicago Medicine, based on a 6 - month clinical trial, finds that use of a CGM is cost - effective for adult patients with type 1 diabetes when compared to daily use of test strips.

Perhaps this technology could be integrated into a portable device, such as the glucometer used by patients with diabetes.»

Soggia and her colleagues explored the possibility of bariatric surgery as a treatment for diabetes in patients with mild obesity (body mass index 30 to 35) by comparing two different types of surgery for weight loss with clinical treatment for diabetes in their hospital patients.

Now used by millions of people with Type 2 diabetes, the drug helps to protect patients from diabetes - related complications, including blindness, kidney failure, and nerve damage.

«Coronary plaque volume index by CCTA is not only clinically feasible and reproducible in patients with diabetes,» said David A. Bluemke, M.D., Ph.D., from the NIH Clinical Center.

The patients without diabetes produced autoantibodies that completely impaired the activity of a subtype of interferon known as interferon - alpha, which is produced by the immune cells and may cause inflammation.

This week, he and his colleagues report a potentially significant step toward that goal: a recipe that can turn human stem cells into functional pancreatic β cells — the cells that are destroyed by the body's own immune system in type 1 diabetes patients such as Melton's son and daughter.

Doctors traditionally screen patients for diabetes during their second or third trimester by looking at risk factors including age, ethnicity, body mass index, family history of diabetes and the results of a glucose challenge test.

Dr. Sonjia Kenya, Ed.D. and her colleagues at the University of Miami Miller School of Medicine examined the extent to which Hispanic patients with diabetes understood how to use their glucometers by querying community health workers.

«New pharmacologic options are welcomed by practicing clinicians like me who struggle to work with our patients who have diabetes — each of whom have unique circumstances that require customized approaches,» says Dr. Vivian Fonseca, M.D., Chief, Section of Endocrinology, Tulane University Medical Center, New Orleans, Louisiana, and author of a paper describing new pharmacological advances in the management of type 2 diabetes.

In the paper «Having their say: Patients» Perspectives and the Clinical Management of Diabetes,» Dr. Leonard Jack, Jr., Ph.D., M.Sc., Director of the Division of Community Health at the National Center for Chronic Disease and Health Promotion, and his co-authors Dr. Leandris C. Liburd, Ph.D., M.P.H., M.A. and Dr. Pattie Tucker, Dr.P.H., M.P.H. and R.N., propose that healthcare providers can offer more effective diabetes support to their patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health oPatients» Perspectives and the Clinical Management of Diabetes,» Dr. Leonard Jack, Jr., Ph.D., M.Sc., Director of the Division of Community Health at the National Center for Chronic Disease and Health Promotion, and his co-authors Dr. Leandris C. Liburd, Ph.D., M.P.H., M.A. and Dr. Pattie Tucker, Dr.P.H., M.P.H. and R.N., propose that healthcare providers can offer more effective diabetes support to their patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health oDiabetes,» Dr. Leonard Jack, Jr., Ph.D., M.Sc., Director of the Division of Community Health at the National Center for Chronic Disease and Health Promotion, and his co-authors Dr. Leandris C. Liburd, Ph.D., M.P.H., M.A. and Dr. Pattie Tucker, Dr.P.H., M.P.H. and R.N., propose that healthcare providers can offer more effective diabetes support to their patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health odiabetes support to their patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health opatients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health outcomes.

In contrast, type 2 diabetes patients who saw only their primary care providers during that time reduced their A1C concentrations by just 0.8 percentage points.

It consists of providing the insulin pumps used by type 1 diabetes mellitus patients with an additional system (control algorithm) able to indicate the exact quantity of insulin needed by a patient at any time.